RADIENT PHARMACEUTICALS Corp 4
4 · RADIENT PHARMACEUTICALS Corp · Filed Oct 19, 2009
Insider Transaction Report
Form 4
Ariura Akio
Chief Financial Officer
Transactions
- Award
Options
2009-10-14$0.75/sh+27,027$20,270→ 27,027 totalExercise: $0.75From: 2006-10-09Exp: 2011-10-08→ Common Stock (27,027 underlying) - Other
Common Stock
2009-09-08−100,000→ 0 total - Award
Options
2009-10-14$0.75/sh+50,000$37,500→ 90,000 totalExercise: $0.75From: 2007-06-01Exp: 2012-05-31→ Common Stock (50,000 underlying) - Award
Options
2009-10-14$0.75/sh+12,973$9,730→ 40,000 totalExercise: $0.75From: 2006-10-09Exp: 2011-10-08→ Common Stock (12,973 underlying) - Award
Options
2009-10-14$0.75/sh+50,000$37,500→ 140,000 totalExercise: $0.75From: 2008-03-03Exp: 2013-03-03→ Common Stock (50,000 underlying)
Footnotes (5)
- [F1]2008-2009 Performance and Equity Plan was not approved by Shareholders at the annual meeting
- [F2]Repricing of the exercise price of options originally granted October 9, 2006 with an exercise price of $3.70
- [F3]Repricing of the exercise price of options originally granted October 9, 2006 with an exercise price of $3.70
- [F4]Repricing of the exercise price of options originally granted June 1, 2007 with an exercise price of $4.06
- [F5]Repricing of the exercise price of options originally granted March 3, 2008 with an exercise price of $3.45